Experiences with acute kidney injury complicating non-fulminant hepatitis A

Nephrology (Carlton). 2008 Dec;13(6):451-8. doi: 10.1111/j.1440-1797.2008.00974.x. Epub 2008 Jun 1.

Abstract

Aim: To describe the clinical features and to identify factors related to development of acute kidney injury in acute hepatitis A patients.

Methods: The study and control groups consisted of 21 and 425 patients who did or did not develop acute kidney injury, respectively, after acute hepatitis A from January 1997 to May 2007.

Results: There were 13 men and eight women; their mean age at diagnosis was 28.8 +/- 8.2 years in the study group. Peak values for renal and liver function impairment consisted of a median serum creatinine of 4.6 mg/dL (range, 1.5-15.3 mg/dL) on day 6 (range, days 1-20) and a median total bilirubin of 10.7 mg/dL (range, 2.6-57.5 mg/dL) on day 8 (range, day 1-19). Serum creatinine concentrations returned to baseline level by a median of 16 days and total bilirubin levels returned to normal by a median of 62 days. Six of 21 (29%) patient underwent haemodialysis. Renal biopsies performed in two patients showed acute tubular necrosis and interstitial nephritis, respectively. Logistic regression analysis showed that a lower haematocrit, the presence of coagulopathy and high C-reactive protein concentration on admission, and higher peak bilirubin value during the illness were associated with development of acute kidney injury.

Conclusion: Acute hepatitis A should be considered in the differential diagnosis of patients with acute kidney injury, even without fulminant hepatic failure. A lower haematocrit, the presence of coagulopathy and high C-reactive protein level at presentation, and higher peak bilirubin level during the illness were associated with development of acute kidney injury in acute hepatitis A patients.

MeSH terms

  • Acute Disease
  • Adult
  • Biopsy
  • C-Reactive Protein / analysis
  • Creatinine / blood
  • Female
  • Hepatitis A / complications*
  • Humans
  • Kidney / pathology
  • Kidney Diseases / etiology*
  • Male

Substances

  • C-Reactive Protein
  • Creatinine